Synthesis Capital’s $300 Million Launch of Synthesis Capital Fund I LP

Carey Olsen, working alongside lead counsel Sidley Austin LLP, advised Synthesis Capital on the matter. Foodtech and alternative protein investor Synthesis Capital (Synthesis) has launched and closed its debut fund, Synthesis Capital Fund I LP (the Fund), a Guernsey Green Fund, with commitments in excess of US$300 million.

The pioneering Fund, which will look to back technology solutions that will help global food system and environmental challenges, was oversubscribed, and has attracted investment from institutional investors, corporate partners, family offices and high net worth angel investors. It is believed to be the largest ever fund raised in the foodtech sector and comes a little over a year since the establishment of the London-based investment manager.

The Fund will look to invest in around 15 companies across the food value chain.

The Fund has already invested in a range of businesses, including the likes of cultivated meat startup Upside Foods, sans bovine ice cream maker Perfect Day, biomanufacturing-as-a-service platform Culture Biosciences, and 3D printing tech startup Redefine Meat.

The Carey Olsen team was led by partner David Crosland (Picture), assisted by senior associate Alex Mauger and associate Claire Cooke.
Involved fees earner: Claire Cooke – Carey Olsen; David Crosland – Carey Olsen; Alex Mauger – Carey Olsen; Law Firms: Carey Olsen; Clients: Synthesis;

Author: Giulia Di Palma